Alginate encapsulation

Alginate encapsulation has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Oct 26, 2026: “Combined B2M Knockout and Alginate Encapsulation Reduces Immune Rejection of iPSC-Derived Pancreatic Progenitors”.

Intervention

1 paper studies it1 findingUpdated

1 new paper in 30 daysSee all 1 papers on alginate encapsulation

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: Russian Science Foundation
  • Animals1

What did studies of alginate encapsulation find?

1

Studies of alginate encapsulation measured one outcome, T-cell activation.

T-cell activation

downin human cells1

1 study
  1. Alginate encapsulation decreases T-cell activation in human cells (Co-culture with encapsulated progenitors versus non-encapsulated controls).

    “T-cells did show residual activation after 7 days of co-culture with encapsulated progenitors, albeit significantly reduced in comparison with non-encapsulated controls.”

    CellsCo-culture with encapsulated progenitors versus non-encapsulated controlsT cell7 days

    Combined B2M Knockout and Alginate Encapsulation Reduces Immune Rejection of iPSC-Derived Pancreatic Progenitors

    Cells

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months